March 2025 in “International Journal of Trichology” This study found that, in female patients with pattern hair loss, injections of adipose-derived stem cells increased hair density and thickness, reduced perifollicular inflammation, and enhanced markers associated with hair cycle regeneration.
February 2025 in “Journal of Pharma Insights and Research.” In this study, researchers developed a novel dry shampoo powder using traditional Indian botanicals and found that it demonstrated effective cleansing properties, favorable physicochemical characteristics, and no adverse effects in animal safety evaluations, offering an eco-friendly alternative to synthetic shampoos.
January 2025 in “Dermatology Practical & Conceptual” This study found topical finasteride and minoxidil both improved hair loss clinically and trichoscopically more effectively than spironolactone in women with female pattern hair loss.
January 2025 in “International Journal of Dermatology Venereology and Leprosy Sciences” This review discusses the various off-label treatments for alopecia areata, highlighting that these therapies may promote hair growth but are not curative.
November 2024 in “Cells Tissues Organs” This study found that human umbilical cord blood-derived mesenchymal stem cells (HUCB-MSCs) improved hair growth and follicle structure in male rats with androgenic alopecia, achieving better results and longer-lasting effects compared to minoxidil treatment, with no observed side effects.
October 2024 in “International Journal of Research in Dermatology” In this retrospective study, tofacitinib showed promise as a treatment for alopecia areata, with 46.5% of patients experiencing a very good response and minimal adverse effects, suggesting it could be a primary option for moderate to severe cases.
This study in adult male albino rats reported that human umbilical cord blood-derived mesenchymal stem cells were more effective than minoxidil in promoting hair growth for androgenic alopecia, observing superior outcomes in hair follicle metrics.
September 2024 in “Ain Shams Medical Journal” This review discusses the prevalence, pathogenesis, and treatments of androgenic alopecia but reports no new research findings; the authors emphasize the need for further exploration of novel treatment options.
July 2024 in “International Journal of Dermatology Venereology and Leprosy Sciences” This pilot clinical trial observed that combining subcision using a blunt cannula with platelet-rich plasma injections and microneedling for post-acne rolling scars was associated with a significant positive correlation between physician satisfaction and age of acne onset.
April 2024 in “The Egyptian Family Medicine Journal/The Egyptian Family Medicine Journal ” This randomized controlled trial found that vitamin D supplementation significantly improved various post-COVID-19 symptoms, such as fatigue and sleep disturbances, compared to placebo over two months, emphasizing the role of vitamin D deficiency in persistent symptoms among post-COVID-19 patients.
January 2024 in “International Journal of Dermatology Research” This randomized clinical trial found that both topical ethinylestradiol 0.01% combined with minoxidil 2% and minoxidil 2% alone were similarly effective in enhancing hair growth for female pattern hair loss, though minoxidil alone was better tolerated with fewer side effects over 24 weeks.
November 2023 in “International Journal of Trichology” This study, conducted at a tertiary care hospital, found no statistically significant association between male pattern hair loss and levels of serum ferritin or thyroid-stimulating hormone, suggesting these factors may not play a role in this condition.
September 2023 in “Deleted Journal” This study, conducted at the Surgical Outpatient Clinics of the Medical Research Institute in Alexandria, Egypt, found that post-bariatric surgery patients commonly experienced gastrointestinal and dermatological issues, fatigue, impaired physical activity, and psychological conditions like anxiety within the first year after surgery.
January 2023 in “Annals of Dermatology” This study found that alopecia areata patients with a CCHCR1 gene variant had higher recurrence rates and structural abnormalities in hair compared to those without the variant.
December 2022 in “Research Square (Research Square)” This study found that isotretinoin treatment significantly increased p53 expression in the skin of acne patients, inversely correlating with acne severity and body mass index.
May 2022 in “Research Square (Research Square)” This study found that isotretinoin treatment significantly increased p53 expression in the skin of acne vulgaris patients, which may help explain its effects on sebum production and adverse effects.
April 2022 in “The Egyptian Journal of Hospital Medicine” This review examines the use of platelet rich fibrin for treating post-acne scars and reports no new clinical results; it highlights that fibrin's matrix enables a prolonged release of growth factors.
January 2022 in “International Journal of Medical Research” This article discusses the negative impact of chemotherapy on healthy cells, noting side effects like decreased blood cell production and hair loss, but reports no new findings.
August 2021 in “Oxford University Press eBooks” This article discusses various aspects of hair restoration, emphasizing the need for individualized treatment plans, and reports no new research findings.
December 2020 in “bioRxiv (Cold Spring Harbor Laboratory)” In this study, 25% of CCHCR1-deficient mice exposed to stress developed hair loss similar to human alopecia areata, suggesting CCHCR1 is a susceptibility gene for the disease.
November 2020 in “Universal Journal of Pharmaceutical Research” In this study, tacrolimus-based treatment was found to result in fewer overall side effects compared to cyclosporine among Yemeni kidney transplant patients, although tacrolimus was associated with a higher incidence of diabetes.
February 2020 in “Zagazig University Medical Journal” In this study, 40 alopecia areata patients applied a combination of adapalene gel and mometasone furoate cream for 6 months, leading to 35% achieving full hair regrowth, though 85% experienced mild side effects like irritation.
January 2020 in “Journal of St. Marianna University” This study found that human placenta extract may enhance hair growth by increasing PG-E2 and PG-F2a production while decreasing PG-D2 levels in cultured hair follicle keratinocytes.
March 2019 in “Oxford University Press eBooks” This chapter reviews surgical and non-surgical treatments for scalp and facial hair management but provides no new clinical findings, highlighting the need for multidisciplinary awareness and access to diverse therapies.
May 2018 in “White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)” In this study, researchers found that alopecia areata patients show a significant reduction in suppressive regulatory T-cells and an increase in inflammatory T-cell populations, suggesting an immunological imbalance contributing to the disease.
August 2017 in “International journal of research in dermatology” This study found that topical 0.05% betamethasone dipropionate was the most effective treatment for patients with patchy alopecia areata, with less than 25% hair loss, over a 12-week period, compared to other topical treatments.
This review explores the synthesis and potential of azasteroids as novel drugs, discussing challenges in their production and reporting no new clinical results.
June 2016 in “The Egyptian Journal of Forensic Sciences and Applied Toxicology” In this study, long-term occupational exposure to benzene in fueling workers was associated with increased skin diseases, altered blood cell counts, and elevated liver enzyme levels compared to overseers.
May 2015 in “Journal of the Egyptian Women's Dermatologic Society /Journal of the Egyptian Women's Dermatologic Society”